Verona Pharma
在场
Verona Pharma 是一家在股票代码 I9SA (GB) 下上市的公司。
高管
查看带有其 20 名主要高管的组织结构图
Verona Pharma 搜索最多的简介
- David Zaccardelli, President and Chief Executive Officer
- Lisa Deschamps, Non Executive Director
- Vikas Sinha, Director
创建提醒
跟踪 Verona Pharma 的高管变动
生物技术
Verona Pharma 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Verona Pharma 的最新新闻稿
- News & SEC Filings - Verona Pharma
- Verona Pharma Announces December 2024 Investor Conference Participation - Verona Pharma
- News & SEC Filings - Verona Pharma
- Verona Pharma to Present at Jefferies London Healthcare Conference - Verona Pharma
- Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Verona Pharma
- News & SEC Filings - Verona Pharma
- Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Verona Pharma
- News & SEC Filings - Verona Pharma
- Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024 - Verona Pharma
- Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024 - Verona Pharma
- View more press releases Close
通过电子邮件
